Peng, Y.; Jiang, H.; Li, B.; Liu, Y.; Guo, B.; Gan, W.
A NIR-Activated and Mild-Temperature-Sensitive Nanoplatform with an HSP90 Inhibitor for Combinatory Chemotherapy and Mild Photothermal Therapy in Cancel Cells. Pharmaceutics 2023, 15, 2252.
https://doi.org/10.3390/pharmaceutics15092252
AMA Style
Peng Y, Jiang H, Li B, Liu Y, Guo B, Gan W.
A NIR-Activated and Mild-Temperature-Sensitive Nanoplatform with an HSP90 Inhibitor for Combinatory Chemotherapy and Mild Photothermal Therapy in Cancel Cells. Pharmaceutics. 2023; 15(9):2252.
https://doi.org/10.3390/pharmaceutics15092252
Chicago/Turabian Style
Peng, Yingying, Hanlin Jiang, Bifei Li, Yue Liu, Bing Guo, and Wei Gan.
2023. "A NIR-Activated and Mild-Temperature-Sensitive Nanoplatform with an HSP90 Inhibitor for Combinatory Chemotherapy and Mild Photothermal Therapy in Cancel Cells" Pharmaceutics 15, no. 9: 2252.
https://doi.org/10.3390/pharmaceutics15092252
APA Style
Peng, Y., Jiang, H., Li, B., Liu, Y., Guo, B., & Gan, W.
(2023). A NIR-Activated and Mild-Temperature-Sensitive Nanoplatform with an HSP90 Inhibitor for Combinatory Chemotherapy and Mild Photothermal Therapy in Cancel Cells. Pharmaceutics, 15(9), 2252.
https://doi.org/10.3390/pharmaceutics15092252